PROVECTUS PHARMA INTERNATIONAL AS
Operating
Investering i aksjer, både noterte og unoterte, deltakelse i andre
selskaper og investering i fast eiendom, og annet som hører naturlig
til.
Investering i aksjer og eiendom.
Organization
- Chairman of the board
- JA
- Years since formation
- 4 years
- since Dec 8, 2022
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 300
- 1 share class
- Total number of shareholders
- 4
- companies
- Belongs to group of
Financials
- Annual total result 2025
- -84,255
- NOK
- Total equity 2025
- 212,600
- NOK
Last update: Jun 20, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
JA | Chairman | 30 % indirectly |
EL | Board Member | 30 % indirectly |
RL | Board Member | 30 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - | |
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
EL | Board Member | 30 % indirectly |
JA | Chairman | 30 % indirectly |
RL | Board Member | 30 % indirectly |
MH | - | 10 % indirectly |
Last update: Jul 29, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 90 | 30 % | |
| Ordinary shares | 90 | 30 % | |
| Ordinary shares | 90 | 30 % | |
| Ordinary shares | 30 | 10 % |
Shares owned by the PROVECTUS PHARMA INTERNATIONAL AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,200 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -82,484Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 0 | 0 | 0 |
Annual Total Result | -84,255 | -47,229 | -15,917 |
Total assets | 610,547 | 580,845 | 351,958 |
Total liabilities | 397,948 | 283,991 | 7,875 |
Total equity | 212,600 | 296,854 | 344,083 |
P&L
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total operating income | 0 | 0 | 0 |
Total operating costs | 82,484 | 46,685 | 15,917 |
Operating result | -82,484 | -46,685 | -15,917 |
Financial income/costs | -1,771 | -544 | 0 |
Profit before tax | -84,255 | -47,229 | -15,917 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -84,255 | -47,229 | -15,917 |
Balance overview
| Year | 2025 | 2024 | 2022 |
|---|---|---|---|
Total fixed assets | 360,000 | 330,000 | 330,000 |
Total current assets | 250,547 | 250,845 | 21,958 |
Total assets | 610,547 | 580,845 | 351,958 |
Short term debt | 397,948 | 283,991 | 7,875 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 397,948 | 283,991 | 7,875 |
Contributed capital | 360,000 | 360,000 | 360,000 |
Retained earnings | -147,400 | -63,146 | -15,917 |
Total equity | 212,600 | 296,854 | 344,083 |
Total equity and liabilities | 610,547 | 580,845 | 351,958 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises